- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.88 Form of Notice of Grant of Stock Options
- 10.89 Stock Ownership Policy
- 21 Subsidiaries of Registrant
- 23.1 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
- 23.2 Consent of Haskell White LLP, Independent Registered Public Accouting Firm
- 31.1 Certification of Chief Executive Officer - Section 302
- 31.2 Certification of Chief Financial Officer - Section 302
- 32 Certification Pursuant to 18 U.s.c. Section 1350 - Section 906
Exhibit 10.88
Cortex Pharmaceuticals, Inc. | ||
Notice of Grant of Stock Options and Option Agreement | ID: 33-0303583 15231 Barranca Parkway Irvine, CA 92618 (949) 727-3157 |
(Insert grantee name) | Option Number: (Insert option number) | |
(Insert grantee street address) | Plan: (Insert stock option plan) | |
(Insert grantee City, State, Zip Code) | ID: (Insert ID) |
Effective (insert grant date), you have been granted a(n) (insert Incentive or Non-qualified) Stock Option to buy (insert number of shares) shares of Cortex Pharmaceuticals, Inc. (the Company) stock at $(insert exercise price) per share.
The total option price of the shares granted is $(insert total option price).
Shares in each period will become fully vested on the date shown.
Shares (insert number of shares vesting) | Vest Type (insert vest type) | Full Vest (insert date) | Expiration (insert date) |
By your signature and the Company’s signature below, you and the Company agree that these options are granted and governed by the terms and conditions of the Company’s Stock Option Plan as amended and the Option Agreement, all of which are attached and made a part of this document.
Cortex Pharmaceuticals, Inc. | Date | |||||||
(Insert grantee name) | Date |